Hartman Institute for Therapeutic Organ Regeneration

Nanog-like regulates endoderm formation through the Mxtx2-Nodal pathway.

TitleNanog-like regulates endoderm formation through the Mxtx2-Nodal pathway.
Publication TypeJournal Article
Year of Publication2012
AuthorsXu C, Fan ZPeng, Müller P, Fogley R, DiBiase A, Trompouki E, Unternaehrer J, Xiong F, Torregroza I, Evans T, Megason SG, Daley GQ, Schier AF, Young RA, Zon LI
JournalDev Cell
Volume22
Issue3
Pagination625-38
Date Published2012 Mar 13
ISSN1878-1551
KeywordsAmino Acid Sequence, Animals, Embryo, Nonmammalian, Endoderm, Gene Expression Regulation, Developmental, Homeodomain Proteins, Intracellular Signaling Peptides and Proteins, Molecular Sequence Data, Nanog Homeobox Protein, Nodal Signaling Ligands, Zebrafish, Zebrafish Proteins
Abstract

<p>In mammalian embryonic stem cells, the acquisition of pluripotency is dependent on Nanog, but the in vivo analysis of Nanog has been hampered by its requirement for early mouse development. In an effort to examine the role of Nanog in vivo, we identified a zebrafish Nanog ortholog and found that its knockdown impaired endoderm formation. Genome-wide transcription analysis revealed that nanog-like morphants fail to develop the extraembryonic yolk syncytial layer (YSL), which produces Nodal, required for endoderm induction. We examined the genes that were regulated by Nanog-like and identified the homeobox gene mxtx2, which is both necessary and sufficient for YSL induction. Chromatin immunoprecipitation assays and genetic studies indicated that Nanog-like directly activates mxtx2, which, in turn, specifies the YSL lineage by directly activating YSL genes. Our study identifies a Nanog-like-Mxtx2-Nodal pathway and establishes a role for Nanog-like in regulating the formation of the extraembryonic tissue required for endoderm induction.</p>

DOI10.1016/j.devcel.2012.01.003
Alternate JournalDev Cell
PubMed ID22421047
PubMed Central IDPMC3319042
Grant ListR01 HL048801 / HL / NHLBI NIH HHS / United States
R01 GM056211 / GM / NIGMS NIH HHS / United States
HL056182 / HL / NHLBI NIH HHS / United States
R01 HL048801-18 / HL / NHLBI NIH HHS / United States
R37 HL056182 / HL / NHLBI NIH HHS / United States
5R01HL048801-18 / HL / NHLBI NIH HHS / United States
R01 HG002668 / HG / NHGRI NIH HHS / United States
5U01HL10001-02 / HL / NHLBI NIH HHS / United States
/ HHMI / Howard Hughes Medical Institute / United States
R01 HL048801-19 / HL / NHLBI NIH HHS / United States
U01 HL100001 / HL / NHLBI NIH HHS / United States
R01 HL056182 / HL / NHLBI NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065